Redsense Medical AB (publ) (XSAT:REDS)
3.930
-0.140 (-3.44%)
At close: Aug 6, 2026
Redsense Medical AB Revenue
Redsense Medical AB had revenue of 7.20M SEK in the quarter ending March 31, 2026, with 47.51% growth. This brings the company's revenue in the last twelve months to 29.12M, down -16.37% year-over-year. In the year 2025, Redsense Medical AB had annual revenue of 26.80M, down -17.85%.
Revenue (ttm)
29.12M
Revenue Growth
-16.37%
P/S Ratio
2.25
Revenue / Employee
5.74M
Employees
5
Market Cap
64.63M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.80M | -5.83M | -17.85% |
| Dec 31, 2024 | 32.63M | 7.07M | 27.66% |
| Dec 31, 2023 | 25.56M | 7.77M | 43.66% |
| Dec 31, 2022 | 17.79M | 889.00K | 5.26% |
| Dec 31, 2021 | 16.90M | -250.46K | -1.46% |
| Dec 31, 2020 | 17.15M | 2.32M | 15.67% |
| Dec 31, 2019 | 14.83M | 6.13M | 70.38% |
| Dec 31, 2018 | 8.70M | 6.63M | 318.93% |
| Dec 31, 2017 | 2.08M | -3.67M | -63.84% |
| Dec 31, 2016 | 5.74M | 3.69M | 179.99% |
| Dec 31, 2015 | 2.05M | -169.10K | -7.61% |
| Dec 31, 2014 | 2.22M | 263.88K | 13.48% |
| Dec 31, 2013 | 1.96M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Mendole | 189.92M |
| SolidX AB | 137.67M |
| QBNK Holding AB | 40.26M |
| Kontigo Care AB | 35.20M |
| Touchtech AB | 23.01M |
| Genetic Analysis AS | 21.06M |
| PEPTONIC medical AB | 14.17M |
| OurLiving AB | 10.26M |
Redsense Medical AB News
- 2 months ago - Redsense Medical AB Quarterly report: Q1 2026 - Filings
- 6 months ago - Redsense Medical AB Annual report: Q4 2025 - Filings
- 6 months ago - Redsense Medical AB Quarterly report: Q4 2025 - Filings
- 9 months ago - Redsense Medical AB Quarterly report: Q3 2025 - Filings
- 1 year ago - Redsense Medical AB Quarterly report: Q2 2025 - Filings